ONC- Beone Medicines Ltd.

Name: Beone Medicines Ltd. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Beone Medicines Ltd. (ONC) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 58 sells. ONC is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Wang Xiaodong	4.58M	$1.45B	-
Pres	Wang Lai	1.45M	$460.10M	-
Dir	Baker Bros. Advisors LP	148.1K	$46.94M	-
VP	Lee Chan Henry	97.0K	$30.76M	-
Dir	Hooper Anthony C	64.7K	$20.52M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 7, 2026	Lee Chan Henry47	SVP, General Counsel	Sale+OE	664	$331.76	$220,288.64	-100%	-9.0%	-
Dec 16, 2025	Oyler John60	Chief Executive Officer	Sell	100,000	$306.59	$30,659,418.82	-9.7%	-4.8%	-
Dec 11, 2025	Lee Chan Henry47	SVP, General Counsel	Sale+OE	664	$321.64	$213,568.96	-100%	-6.8%	-
Nov 26, 2025	Sanders Corazon (corsee) D.69	Director	Sale+OE	2,627	$340.90	$895,534.43	-76.6%	+8.3%	-
Nov 17, 2025	Wu Xiaobin54	President And COO	Sell	3,991	$380.43	$1,518,302.84	-82.5%	-5.8%	-
Nov 13, 2025	Wu Xiaobin54	President And COO	Sell	16,009	$365.22	$5,846,820.22	-15.6%	-4.6%	-
Nov 12, 2025	Lee Chan Henry47	SVP, General Counsel	Sale+OE	996	$349.17	$347,770.00	-75.0%	-6.4%	-
Oct 8, 2025	Lee Chan Henry47	SVP, General Counsel	Sale+OE	10,671	$350.40	$3,739,107.61	-45.0%	-8.8%	-
Sep 16, 2025	Oyler John60	Chief Executive Officer	Sell	27,803	$325.71	$9,055,693.88	-38.0%	-5.1%	-
Sep 10, 2025	Lee Chan Henry47	SVP, General Counsel	Sale+OE	10,006	$325.53	$3,257,288.87	-64.9%	+1.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC